CEL-SCI Corporation
CEL-SCI Corporation (CVM) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
cvm · pe ratio · data through Sep 30, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for CEL-SCI Corporation (CVM) measures how much investors pay for each dollar of the company's trailing earnings. CVM's current PE ratio of N/A is calculated by dividing its stock price of $1.42 by its TTM earnings per share of -$2.79.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-09-30
PE Ratio History
2006 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Biotechnology · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
CEL-SCI CorporationYou CVM | $10M | N/A | — | -$2.79 |
 Aligos Therapeutics, Inc. ALGS | $32M | N/A | — | -$2.45 |
 Barinthus Biotherapeutics plc BRNS | $30M | N/A | — | -$1.64 |
 FibroGen, Inc. FGEN | $37M | 0.19x | — | $45.38 |
 INmune Bio, Inc. INMB | $34M | N/A | — | -$1.73 |
 Kezar Life Sciences, Inc. KZR | $54M | N/A | — | -$7.66 |
 Mersana Therapeutics, Inc. MRSN | $145M | N/A | — | -$14.12 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-09-30Latest FY2025 | — | $-6.27 | — | |
2024-09-30 FY2024 | — | $-13.54 | — | |
2023-09-30 FY2023 | — | $-21.83 | — | |
2022-09-30 FY2022 | — | $-26.61 | — | |
2021-09-30 FY2021 | — | $-28.91 | — | |
2020-09-30 FY2020 | — | $-26.30 | — | |
2019-09-30 FY2019 | — | $-21.74 | — | |
2018-09-30 FY2018 | — | $-1685.05 | — | |
2017-09-30 FY2017 | — | $-1638.03 | — | |
2016-09-30 FY2016 | — | $-62.78 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for CEL-SCI Corporation (CVM) measures how much investors pay for each dollar of the company's trailing earnings. CVM's current PE ratio of N/A is calculated by dividing its stock price of $1.42 by its TTM earnings per share of -$2.79.
Frequently asked questions
CVM pe ratio · 6 questionsCVM's current PE ratio is N/A as of 2026-06-09, based on a stock price of $1.42 and TTM EPS of -$2.79. Data sourced from Financial Modeling Prep via CVM's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · CEL-SCI Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09